Plain radiography or magnetic resonance imaging (MRI): Which is better in assessing outcome in clinical trials of disease-modifying osteoarthritis drugs? Summary of a debate held at the World Congress of Osteoarthritis 2014

Published 2015 View Full Article

Title

Plain radiography or magnetic resonance imaging (MRI): Which is better in assessing outcome in clinical trials of disease-modifying osteoarthritis drugs? Summary of a debate held at the World Congress of Osteoarthritis 2014

Authors

Keywords

Osteoarthritis–clinical trial–disease-modifying OA drugs (DMOADs), Radiography, Joint space width (JSW), Magnetic resonance imaging (MRI), Cartilage thickness

Journal

SEMINARS IN ARTHRITIS AND RHEUMATISM

Volume 45, Issue 3, Pages 251-256

Publisher

Elsevier BV

Online

2015-06-07

DOI

10.1016/j.semarthrit.2015.06.001

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

© Peeref 2019-2024. All rights reserved.